Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abolished, acceptabletolerability, accreted, accrual, added, adenocarcinoma, affirmed, aggressive, AIA, aim, allelic, Allen, anagrelide, Analyst, andcommercialization, andour, andxenograft, anumber, appealedthe, argued, asgrowth, aspiration, Avastin, Beisheim, Big, biomedical, bond, Booz, breastcancer, burden, byprescription, byViaCyte, cannotpredict, capecitabine, carboplatin, Chicago, choice, chosen, CIRM, cisplatin, cleaved, clinicalresearch, clinicaltesting, compelling, composition, concept, contractor, Cooley, coordinated, cosmetic, count, Covance, CPMP, cranial, crizotinib, cytoreductive, database, Ddirectly, deal, debulking, decade, decisionfrom, decisionsin, deep, deficiency, Deutsche, disburse, disbursement, discontinuation, discontinue, discontinued, discontinuing, disorder, divest, divestiture, divesture, dosage, doublet, drugdiscovery, dysfunction, Earlham, Eastern, ECJ, elasticity, Elevated, EMA, endothelial, endpoint, Epidemiology, epidermal, erlotinib, essentialthrombocythemia, estrogen, eventually, extinguishment, FDAand, follicle, forfeited, forgiven, forother, forproduct, frequently, fundamental, gave, gemcitabine, Germany, Godward, graham, Greenpeace, growthin, growthof, half, Hamilton, headed, hemorrhagic, Herceptin, Hofstra, hydroxyurea, imaging, inassociation, incidence, incident, includingradiation, indrug, inflammatory, infusion, ingredient, inside, Interbank, Interferencesreversed, interferon, InterMune, intolerance, intolerant, invasive, Ipsen, ixabepilone, john, judicial, Justice, kinase, lackthereof, lenalidomide, leveraging, LIBOR, ligand, mayreceive, meaningful, Melanie, monotherapy, morbidity, MPL, mutant, mutation, myeloid, myeloproliferative, Nallicheri, native, neurocognitive, neurotoxicity, newmanufacturing, noncompetitive, nonspecific, Nordisk, North, Northeastern, Notably, Novo, nutraceutical, nutritional, obesity, ofproduct, oftissue, Orexigen, orthotopic, Otto, ourproduct, overalternative, owed, palliate, passed, patentabilityof, patentson, pemetrexed, permeability, PFS, pharma, pharmacologicalactivity, pioneering, platelet, polycythemia, poorly, Pritzker, profile, progesterone, proliferationin, promulgated, Proteolix, pulmonology, radiation, radiosurgery, rapidly, reagent, rebuild, reinitiating, remanded, repaid, resection, retrospectively, RIBBON, rightsto, Roche, Rosenfield, roughly, SA, salvage, sample, scarlett, secondary, SEER, shipped, shrinkage, sinceSeptember, sizable, slower, Southwestern, SRS, stability, stabilization, stable, standing, startup, statistical, stereotactic, stratify, subpopulation, summary, supplier, surgery, surgical, suspension, switch, symptomatic, synergistic, synergistically, technologyfor, Tercica, terminology, thalidomide, themeasurement, thePatent, therelevant, theWisconsin, Thomson, thought, thrombocytopenia, thrombotic, tight, tocommence, toearlier, toserve, trastuzumab, trialsand, triple, unamortized, unanticipated, unavailability, unexpected, unforeseen, unformulated, unregistered, unsuitable, upheld, valueof, veterinary, WBRT, WHU
Removed:
abnormally, accessory, accompanied, activate, activated, addressing, administrator, adult, advancing, afford, aging, agree, altering, AML, Amplification, ancillary, antigen, antisense, appointed, area, Arizona, attached, attack, banked, beef, behavior, billion, biochemical, biodistribution, Biosensor, birth, bladder, block, bloodstream, boost, borne, broadly, building, Cambrex, capable, carcinoma, cardiac, cardiovascular, cattle, chain, chemical, chemically, chromosomal, claimed, clock, clone, coding, collagen, collection, commentary, composed, concentrated, concluding, conduction, congestive, continuously, contractile, contracting, Convention, cooperate, cooperated, cooperation, corrected, covalently, created, cryopreserved, cytoplasm, daily, dairy, damaged, defense, degeneration, degradation, degraded, delaying, delivering, dependence, designate, desired, destructive, detrimental, device, devoted, diabetic, diagnosing, differentiate, differentiated, disabled, diseased, dismissed, diversion, Dolly, donated, donor, dosing, Duke, efficient, egg, electrical, ELISA, embryo, encounter, energy, engineered, engraft, engraftment, enhance, Enlarged, enucleated, enzymatic, essentially, exacerbate, explore, exposing, eye, family, faster, feasibility, female, fertilization, fetal, filled, fix, food, force, formation, foundational, Fusion, generation, genetically, genomic, glucose, graft, great, greenwood, grow, gut, harmful, harming, Harvard, healing, hematology, Histological, hope, Ian, ideal, immortal, immortality, immunity, immunogenicity, Immunology, Immunomic, ImmunoSorbent, impairing, implantation, implanted, implementation, Importantly, impractical, inability, incorporate, indefinite, infarction, informed, inhibitory, injected, injection, insulating, insulation, interaction, interim, intermittent, interpreting, introduce, introduced, isolating, Jane, Junior, jurisdiction, Katharine, kidney, kill, LAMP, largest, Lebkowski, left, legislation, lesion, lifespan, light, limiting, live, livestock, locomotor, longest, Lonza, losing, Lutheran, lymphoproliferative, lysosomal, macular, mainstay, margin, marker, matrix, mature, McKinsey, meat, mediated, membrane, Merck, merged, metabolic, mice, milk, Mitochondrial, modulate, Morgan, mortal, myelin, myelinated, myocardial, narrowly, neuronal, Neuroscience, neurotrophic, NIH, nonfunctional, NPS, objectionable, offspring, okarma, ordinary, Oregon, overgrowth, Pacific, pain, palmitoyl, par, paralyzed, partly, PCR, people, permanently, pharmacodynamic, pharmacokinetic, pharmacological, pill, pluripotency, pluripotent, poison, polymerase, pork, Portland, postpone, poultry, predicted, premium, presence, primitive, Princeton, profiting, progeny, prohibit, prohibition, proliferate, properly, Proposition, prostate, publicity, published, pulsed, question, rapid, rat, ratio, reaction, reconstituted, reexamined, regenerate, regulated, reject, relapsed, released, remodeling, removed, removing, repeat, repeatedly, replicate, replicative, reprogram, Reprogramming, requested, researching, reset, resource, restoring, retained, reverse, ribonucleic, Rice, robust, Rorer, Roslin, scalable, scalably, scaled, scar, screen, selecting, senescent, serial, sheep, shorten, showed, showing, social, Society, somatic, sparing, Spink, spread, stake, structural, studied, subsequently, suffering, sugar, suitable, suppressor, surface, synthesized, Syracuse, TBT, teach, teaching, telephone, Telomeric, therapeutically, thiophosphoramidate, thoracic, tolerizing, toxicology, Trademark, transcriptase, transferred, Transgenic, transiently, transplantation, transplanted, TRAP, uncontrolled, undifferentiated, unit, unpatentable, upregulate, Upregulation, urine, utilizing, vaccination, valve, ventricular, voiced, Walkersville, weekly, weight, Wilmut, wire, wound
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 Form of Indemnification Agreement
- 10.27 Employment Agreement Between the Registrant and Graham Cooper
- 10.29 Transition and Separation Agreement Between the Registrant
- 10.30 Separation Agreement Between the Registrant and Jane S. Lebkowski
- 10.31 Consulting Agreement Between the Registrant and Jane S. Lebkowski
- 10.32 Employment Agreement Between the Registrant and Stephen N. Rosenfield
- 10.36 Office Lease Agreement by and Between the Registrant and Exponent Realty, LLC
- 21.1 List of Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Form of Rule 13A-14(A)
- 31.2 Certification of Chief Financial Officer Pursuant to Form of Rule 13A-14(A)
- 32.1 Certification of Chief Executive Officer Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of Chief Financial Officer Pursuant to 18 U.s.c. Section 1350
Related press release
GERN similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Geron Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that:
(i) | the accompanying annual report on Form 10-K of the Company for the year ended December 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and | ||
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: March 7, 2012 | /s/ JOHN A. SCARLETT |
John A. Scarlett, M.D. | |
President and Chief Executive Officer |
A signed original of this written statement required by Section 906 has been provided to Geron Corporation and will be retained by Geron Corporation and furnished to the Securities and Exchange Commission or its staff upon request.